SIREN : 901103846
LM PHARMAGROUP is a French company founded 4 years ago, specialized in the sector Activités des sociétés holding. Based in LES ABYMES (97139), this company of category PME has financial data available below. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2022 | 2021 |
|---|---|---|
| Revenue | N/C | N/C |
| Net income | 0 € | 0 € |
| EBITDA | N/C | N/C |
| Net margin | N/C | N/C |
In 2022, LM PHARMAGROUP records a net loss of 0 €. This deficit will reduce equity on the balance sheet.
The liquidity ratio (= Current assets / Current liabilities) stands at 91.57. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
91.566
In 2022, the liquidity ratio of LM PHARMAGROUP (91.57) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Compare LM PHARMAGROUP with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of LM PHARMAGROUP is not publicly disclosed (confidential accounts filed with INPI).
Profitability information is not publicly available.
The headquarters of LM PHARMAGROUP is located in LES ABYMES (97139), in the department Guadeloupe.
The tax return of LM PHARMAGROUP is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LM PHARMAGROUP operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.